Hear from an expert about self-collection in a healthcare setting

Be at the forefront of cervical cancer screening with BD Onclarity™ HVP Assay, the first and only FDA-approved HPV assay offering both extended genotyping and self-collection in a healthcare setting.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

James Walker
MLO Online: COVID-19’s impact on testing practices for STIs
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Cervical Cancer | News & Updates
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Politico article
Cervical Cancer | News & Updates
POLITICO: Women don’t know when to get screened for cervical cancer, survey finds